Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Conference

Aspen Cancer Conference Fellows

References

  • Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100(1), 57—70.[Medline] [Order article via Infotrieve]
  • Vivanco, I., and Sawyers, C.L. (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2(7), 489—501.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wendel, H.G., et al., (2004). Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy Nature 428(6980), 332—7.[CrossRef][Medline] [Order article via Infotrieve]
  • Lazaris-Karatzas, A., Montine, K.S., and Sonenberg, N. (1990). Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature 345(6275), 544—7.[CrossRef][Medline] [Order article via Infotrieve]
  • Polunovsky, V.A., et al. (1996). Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Mol Cell Biol 16(11), 6573—81.[Abstract]
  • Crackower, M.A., Scherer, S.W., Rommens, J.M., Hui, C.-C., Poorkaj, P., Soder, S., Cobben, J.M., Hudgins, L., Evans, J.P., and Tsui, L.-C. (1996). Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3—q22.1 and analysis of a candidate gene for its expression during limb development. Hum Mol Genet 5, 571—9.[Abstract/Free Full Text]
  • Zlotogora, J. (1994). On the inheritance of the split hand/split foot malformation. Am J Med Genet 53, 29—32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Marston, N.J., Richards, W.J., Hughes, D., Bertwistle, D., Marshall, C.J., and Ashworth, A. (1999). Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol 19, 4633—42.[Abstract/Free Full Text]
  • Yang, H., Jeffrey, P.D., Miller, J., Kinnucan, E., Sun, Y., Thoma, N.H., Zheng, N., Chen, P.L., Lee, W.H., and Pavletich, N.P. (2002). BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297, 1837—48.[Abstract/Free Full Text]
  • Warren, M., Smith, A., Partridge, N., Masabanda, J., Griffin, D., and Ashworth, A. (2002). Structural analysis of the chicken BRCA2 gene facilitates identification of functional domains and disease causing mutations. Hum Mol Genet 11, 841.[Abstract/Free Full Text]
  • Szabo, C., Masiello, A., Ryan, J.F., and Brody L.C. (2000). The breast cancer information core: database design, structure, and scope. Hum Mutat 16, 123.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kojic, M., Yang, H., Kostrub, C.F., Pavletich, N.P., and Holloman, W.K. (2003). The BRCA2-interacting protein DSS1 is vital for DNA repair, recombination, and genome stability in Ustilago maydis. Mol Cell 12, 1043—49.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wei, S.-J., Trempus, C.S., Cannon, R.E., Botner, C.D., and Tennant, R.W. (2003). Identification of Dss1 as a 12-O-tetradecanoylphorbol-13-acetate-responsive gene expressed in keratinocyte progenitor cells, with possible involvement in early skin tumorigenesis. J Biol Chem 278, 1758— 68.[Abstract/Free Full Text]
  • Colburn, N.H., Former, B.F., Nelson, K.A., and Yuspa, S.H. (1979). Tumour promoter induces anchorage independence irreversibly. Nature 281, 589—91.[CrossRef][Medline] [Order article via Infotrieve]
  • Jäntti, J., Lahdenranta, J., Olkkonen, V.M., Söderlund, H., and Keränen, S. (1999). SEM1, a homologue of the split hand/split foot malformation candidate gene Dss1, regulates exocytosis and pseudohyphal differentiation in yeast. Proc Natl Acad Sci U.S.A. 96, 909—14.[CrossRef]
  • Nishizuka, Y. (1984). The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308, 693— 98.[CrossRef][Medline] [Order article via Infotrieve]
  • Steeg, P.S. (2004). Perspectives on classic article: metastasis suppressor genes. J Natl Cancer Inst 96(6), E4.[Free Full Text]
  • Dong, J.T., Lamb, P.W., Rinker-Schaeffer, C.W., Vukanovic, J., Ichikawa, T., Isaacs, J.T., and Barrett, J.C. (1995). KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268(5212), 884—6.[Abstract/Free Full Text]
  • Liu, F.S., Dong, J.T., Chen, J.T., Hsieh, Y.T., Ho, E.S., and Hung, M.J. (2000). Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. Gynecol Oncol 78(1), 10—5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lozano, E., Betson, M., and Braga, V.M. (2003). Tumor progression: small GTPases and loss of cell-cell adhesion. Bioessays 25(5), 452—63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Marcoux, N., and Vuori, K. (2003). EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2. Oncogene 22(38), 6100—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schiff, P.B., and Horwitz, S.B. (1980). Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77, 1561—65.[Abstract/Free Full Text]
  • Horwitz, S.B. (1992). Mechanism of action of Taxol. Trends Pharmacol Sci 13, 134—6.[CrossRef][Medline] [Order article via Infotrieve]
  • Yvon, A.M., Wadsworth, P., and Jordan, M.A. (1999). Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol Biol Cell 10, 947—59.[Abstract/Free Full Text]
  • Jordan, M.A., Toso, R.J., Thrower, D., and Wilson, L. (1993). Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc Natl Acad Sci USA 90, 9552—6.[Abstract/Free Full Text]
  • Woods, C.M., Zhu, J., McQueney, P.A., Bollag, D., and Lazarides, E. (1995). Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mo Med 1, 506—26.[Web of Science]
  • Torres, K., and Horwitz, S.B. (1998). Mechanism of Taxol-induced cell death are concentration dependent. Cancer Res 58, 3620—6.[Abstract/Free Full Text]
  • Blagosklonny, M.V., and Fojo, T. (1999). Molecular effects of paclitaxel: myths and realty (a critical review). Int. J. Cancer 83, 151—6.[Web of Science][Medline] [Order article via Infotrieve]
  • Wynder, E.L., and Graham, E.A. (1950). Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma: a study of six hundred and eighty-four proved cases. JAMA 143, 329—36.[Abstract/Free Full Text]
  • Stayner, L.T., and Wegman, D.H. (1983). Smoking, occupation, and histopathology of lung cancer: a case-control study with the use of the Third National Cancer Survey. J Natl Cancer Inst 70, 421—6.[Web of Science][Medline] [Order article via Infotrieve]
  • Auerbach, O., Forman, J.B., Gere, J.B., Kassouny, D.Y., Muehsam, G.E., Petrick, T.G., Smolin, H.J., and Stout, A.P. (1957). Changes in the bronchial epithelium in relation to smoking and cancer of the lung; a report of progress. N Engl J Med 256(3), 97—104.[Web of Science][Medline] [Order article via Infotrieve]
  • Hetch, S.S. (1999). Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91(14), 1194—1210.[Abstract/Free Full Text]
  • Denissenko, M.F., Pao, A., Tang, M., and Pfeifer, G.P. (1996). Preferential Formation of Benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274(5286), 430.[Abstract/Free Full Text]
  • Hussain, S.P., Amstad, P., Raja, K., Sawyer, M., Hofseth, L., Shields, P.G., Hewer, A., Phillips, D.H., Ryberg, D., Haugen, A., and Harris, C.C. (2001). Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res 61(17) 6350—5.[Abstract/Free Full Text]
  • Coller, A.H., Khrapko, K., Torres, A., Frampton, M.W., Utell, M.J., and Thilly, W.G. (1998). Mutational spectra of a 100-base pair mitochondrial DNA target sequence in bronchial epithelial cells: a comparison of smoking and nonsmoking twins. Cancer Res 58, 1268—77.[Abstract/Free Full Text]
  • Cha, R.S., Zarbl, H., Keohavong, P., and Thilly, W.G. (1992). Mismatch amplification mutation assay (MAMA): application to the c-H-ras gene. PCR Methods Appl 2(1), 14—20.[Medline] [Order article via Infotrieve]
  • Kure, E.H., Ryberg, D., Hewer, A., Phillips, D.H., Skaug, V., Baera, R., and Haugen, A. (1996). p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis 17(10), 2201—5.[Abstract/Free Full Text]
  • Ciminale, V., Pavlakis, G.N., Derse, D., Cunningham, C.P., and Felber, B.K. (1992). Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J Virol 66, 1737—45.[Abstract/Free Full Text]
  • Koralnik, I.J., Fullen, J., and Franchini, G. (1993). The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol 67, 2360—66.[Abstract/Free Full Text]
  • Mortreux, F., Gabet, A.S., and Wattel, E. (2003). Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 17, 26—38,[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nicot, C. et al. (2004) HTLV-1-encoded p30(II) is a post-transcriptional negative regulator of viral replication. Nat Med.
  • Robek, M.D., Wong, F.H., and Ratner, L. (1998). Human T-Cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J Virol 72, 4458—62.[Abstract/Free Full Text]
  • Uchiyama, T. (1997). Human T cell leukemia virus type I (HTLV-I) and human diseases. [Review] [134 refs]. Annual Review of Immunology 15,15— 37, 15—37.
  • Zhang, W. et al. (2001). Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300. J Virol 75, 9885— 95.[Abstract/Free Full Text]
  • Zhang, W., Nisbet, J.W., Bartoe, J.T., Ding, W., and Lairmore, M.D. (2000). Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters. J Virol 74, 11270—7.[Abstract/Free Full Text]
  • Hickson, I.D. (2003). RecQ helicases: caretakers of the genome. Nat Rev Cancer 3, 169—78.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sengupta, S., Linke, S.P., Pedeux, P., et al. (2003). BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination. Embo J 22, 1210— 22.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Davies, S.L., North, P.S., Dart, A., et al. (2004). Phosphorylation of the Bloom's syndrome helicase and its role in recovery from S-phase arrest. Mol Cell Biol 24, 1279—91.[Abstract/Free Full Text]
  • Abraham, R.T. (2002). Checkpoint signalling: focusing on 53BP1. Nat Cell Biol 4, E277—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bartek, J., and Lukas, J. (2003). Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • American Cancer Society. Cancer Facts and Figures. 2003.
  • Tamoxifen for early breast cancer: an overview of the randomised trials. (1998). Early Breast Cancer Trialists' Collaborative Group. Lancet 351, 1451—67.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Assikis, V.J., Neven, P., Jordan, V.C., and Vergote, I.A. (1996). realistic clinical perspective of tamoxifen and endometrial carcinogenesis. Eur J Cancer 32A, 1464—76.[CrossRef]
  • Pyrhonen, S., Ellmen, J., Vuorinen, J., Gershanovich, M., Tominaga, T., Kaufmann, M., and Hayes, D.F. (1999). Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer. Breast Cancer Res Treat 56, 133—43.[Web of Science][Medline] [Order article via Infotrieve]
  • Coller, J.K. (2003). Oxidative metabolism of tamoxifen to Z-4-hydroxy-tamoxifen by cytochrome P450 isoforms: an appraisal of in vitro studies. Clin Exp Pharmacol Physiol 30, 845—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hu, Y., Dehal, S.S., Hynd, G., Jones, G.B., and Kupfer, D. (2003). CYP2D6-mediated catalysis of tamoxifen aromatic hydroxylation with an NIH shift: similar hydroxylation mechanism in chicken, rat and human liver microsomes. Xenobiotica 33, 141—51.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Boocock, D.J., Brown, K., Gibbs, A.H., Sanchez, E., Turteltaub, K.W., and White, I.N. (2002). Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA. Carcinogenesis 23, 1897—901.[Abstract/Free Full Text]
  • Crewe, H.K., Notley, L.M., Wunsch, R.M., Lennard, M.S., and Gillam, E.M. (2002). Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. Drug Metab Dispos 30, 869—74.[Abstract/Free Full Text]
  • Nishiyama, T., Ogura, K., Nakano, H., Ohnuma, T., Kaku, T., Hiratsuka, A., Muro, K., and Watabe, T. (2002). Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases. Biochem Pharmacol 63, 1817—30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nowell, S., Sweeney, C., Winters, M., Stone, A., Lang, N.P., Hutchins, L.F., Kadlubar, F.F., and Ambrosone, C.B. (2002). Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J Natl Cancer Inst 94, 1635—40.[Abstract/Free Full Text]
  • Roth, R.B., and Samson, L.D. (2000). Gene transfer to suppress bone marrow alkylation sensitivity. Mutat Res 462(2—3), 107—20.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Friedberg, E.C., Walker, G.C., and Siede, W. (1995). DNA Repair and Mutagenesis. Washington, D.C.: ASM Press. 698.
  • Begley, T.J., and Samson, L.D. (2003). AlkB mystery solved: oxidative demethylation of N1-methyladenine and N3-methylcytosine adducts by a direct reversal mechanism. Trends Biochem Sci 28(1), 2—5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Engelward, B.P., et al. (1997). Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc Natl Acad Sci USA 94(24), 13087—92.[Abstract/Free Full Text]
  • Glassner, B.J., et al. (1999). DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis 14(3), 339—47.[Abstract/Free Full Text]
  • Sakumi, K., et al. (1997). Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice. Cancer Res 57(12), p. 2415—8.
  • Jelinsky, S.A., and Samson, L.D. (1999). Global response of Saccharomyces cerevisiae to an alkylating agent. Proc Natl Acad Sci USA 96(4), 1486—91.[Abstract/Free Full Text]
  • Jelinsky, S.A., et al. (2000). Regulatory networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae cells: Rpn4 links base excision repair with proteasomes. Mol Cell Biol 20(21), 8157—67.[Abstract/Free Full Text]
  • Baptiste, N., and Prives, C. (2004). p53 in the cytoplasm: a question of overkill? Cell 116, 487—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Butkiewicz, D., Rusin, M., Enewold, L., Shields, P.G., Chorazy, M., and Harris, C.C. (2001). Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22, 593—7.[Abstract/Free Full Text]
  • Dumont, P., Leu, J.I., Pietra, A.C.D., George, D.L., and Murphy, M. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33, 357—65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fan, R., Wu, M., Miller, D., Wain, J.C., Kelsey, K.T., Wiencke, J.K., and Christiani, D.C. (2000). Thep53 codon 72 polymorphism and lung caner risk. CEBP 9, 1037—42.
  • Greenblatt, M.S., Bennett, W.P., Hollstein, M., and Harris, C.C. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54, 4855—78.[Free Full Text]
  • Haugen, A. (2002). Women who smoke: are women more susceptible to tobacco-induced lung cancer? Carcinogenesis 23, 227—9.[Free Full Text]
  • Liu, G., Miller, D.P., Zhou, W., Thurston, S.W., Fan, R., Xu, L., Lynch, T.J., Wain, J., Su, L., and Christiani, D.C. (2001). Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res 61, 8718—22.[Abstract/Free Full Text]
  • Matullo, G., Palli, D., Peluso, M., Guarrera, S., Carturan, S., Celentano, E., Krogh, V., Munnia, A., Tumino, R., Polidoro, S., Piazza, A., and Vineis, P. (2001). XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22, 1437— 45.[Abstract/Free Full Text]
  • Mollerup, S., Ryberg, D., Hewer, A., Phillips, D.H., and Haugen, A. (1999). Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59, 3317—20.[Abstract/Free Full Text]
  • Pfeifer, G.P., and Hainaut, P. (2003). On the origin of G -> T transversions in lung cancer. Mut Res 526, 39—43.[Web of Science][Medline] [Order article via Infotrieve]
  • Siegfried, J.M. (2001). Women and lung cancer: does oestrogen play a role? Lancet Oncol 2, 506—13.[CrossRef][Medline] [Order article via Infotrieve]
  • Spitz, M.R., Wu, X., Wang, Y., Wang, L.E., Shete, S., Amos, C.I., Guo, Z., Lei, L., Mohrenweiser, H., and Wei, Q. (2001). Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61, 1354—7.[Abstract/Free Full Text]
  • Stewart, J.H. (2001). Lung carcinoma in African Americans. Cancer 91, 2476—82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wang, X.W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J.M., Wang, Z., Freidberg, E.C., Evans, M.K., Taffe, B.G., Bohr, V.A., Weeda, G., Hoeijmakers, J.H., Forrester, K., and Harris, C.C. (1995). p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet 10, 188—95.[Web of Science][Medline] [Order article via Infotrieve]
  • Wang, X.W., Vermeulen, W., Coursen, J.D., Gibson, M., Lupold, S.E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J.H., and Harris, C.C. (1996) The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev 10, 1219—32.[Abstract/Free Full Text]
  • Weston, A., Caporaso, N.E., Perrin, L.S., Sugimura, H., Tamai, S., Krontiris, T.G., Trump, B.F., Hoover, R.N., and Harris, C.C. (1992). Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis. Environ Health Perspect 98, 61—7.[Web of Science][Medline] [Order article via Infotrieve]
  • Weston, A., Perrin, L.S., Forrester, K., Hoover, R.N., Trump, B.F., Harris, C.C., and Caporaso, N.E. (1992). Allelic frequency of a p53 polymorphism in human lung cancer. CEBP 1, 481—3.
  • Zhou, W., Liu, G., Miller, D.P., Thurston, S.W., Xu, L.L., Wain, J., Lynch, T.J., Su, L., and Christiani, D.C. (2003). Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking and lung cancer risk. CEBP 12, 359—65.
  • Dillard, A., Leland, J., Wilder, E., and Lane, M.A. (2003). Retinol inhibits the growth of retinoic acid-resistant colon cancer cells via a retinoic acid independent mechanism. FASEB J 17, A1198 (Abstract).
  • Easwaran, V., Pishvaian, M., Byers, S., and Byers, S. (1999). Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Current Biology 9, 1415—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lane, M.A., Chen, A., Roman, S., Derguini, F.L., and Gudas, L.G. (1999). Removal of LIF (leukemia inhibitory factor) results in increased vitamin A (retinol) metabolism to 4-oxoretinol in embryonic stem cells. Proc Natl Acad Sci 96, 13524—9.[Abstract/Free Full Text]
  • Lee, M.O., Han, S.Y., Jiang, S., Park, J.H., and Kim, S.J. (2000). Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associate with induction of retinoic acid receptor b{square}{square}{square}. Biochem Pharm 59, 485—96.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sonneveld, E., van den Brink, C.D., van der Leede, B.M., Schulkes, R., Petkovich, M., van der Burg, B., and van der Saag, P.T. (1998). Human retinoic acid (RA) 4-hydroxylase (cyp26) is highly specific for all-transra and can be induced through RA receptors in human breast and colon carcinoma cells. Cell Growth Differ 9 629—37.[Abstract]
  • Xiao, J.-H., Ghosn, C., Hinchman, C., Forbes, C., Wang, J., Snider, N., Cordrey, A., Zhao, Y., and Chandraratna, R.A.S. (2003) Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. Jrnl Biol Chem 278, 29954—62.[CrossRef]
  • Pahlavani, M.A. (2000). Calorie restriction and immunosenescence: a current perspective. Front Biosci 5, D580—D7.[Web of Science][Medline] [Order article via Infotrieve]
  • Bachmaier, K., Krawczyk, C., Kozieradzki, I., et al. (2000). Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211—16.[CrossRef][Medline] [Order article via Infotrieve]
  • Naramura, M., Kole, H.K., Hu, R.J., et al. (1998). Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci USA 95, 15547—52.[Abstract/Free Full Text]
  • Herlyn, M. (1993). Molecular and cellular biology for melanoma. Medical Intelligence Unit, Landes RG, Austin, 107.
  • Black, J. (1999). Malignant melanoma: an update on treatments. Plastic Surgical Nursing 19, 143—7.[Medline] [Order article via Infotrieve]
  • Gray, R.J., Pockaj, B.A., and Kirkwood, J.M. (2002). An update of adjuvant interferon for melanoma. Cancer Control 9, 16—21.[Medline] [Order article via Infotrieve]
  • DelPrete, S.A., Maurer, L.H., and O'Donnell, J. (1984). Cancer Treat. Report 68, 1403—5.
  • Johnson, R.O., Bisel, H., Andrews, N., Wilson, W., Rochlin, D., Segaloff, A., Krementz, E., Aust, J., and Ansfield, F. (1966). Cancer Chemother Rep 50, 671—3.
  • Barthold, S.W., Coleman, G.L., Jacoby, R.O., Livestone E.M., and Jonas, A.M. (1978). Transmissible murine colonic hyperplasia. Vet Pathol 15, 223— 36.[Abstract]
  • Barthold, S.W., and Jonas, A.M. (1977). Morphogenesis of early 1,2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. Cancer Res 37, 4352—60.[Abstract/Free Full Text]
  • Hennings, H., Glick, A.B., Lowry, D.T., Krsmanovic, L.S., Sly, L.M., and Yuspa, S.H. (1993). FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14, 2353— 8.[Abstract/Free Full Text]
  • Nambiar, P.R., Girnun, G., Lillo, N.A., Guda, K., Whiteley, H.E., and Rosenberg, D.W. (2003). Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. Int J Oncol 22, 145—50.[Web of Science][Medline] [Order article via Infotrieve]
  • Newman, J.V., Kosaka, T., Sheppard, B.J., Fox, J.G., and Schauer, D.B. (2001). Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J Infect Dis 184, 227—30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Riddell, R.H., Goldman, H., Ransohoff, D.F., Appelman, H.D., Fenoglio, C.M., Haggitt, R.C., Ahren, C., Correa, P., Hamilton, S.R., Morson, B.C., Sommers, S.C., and Yardley, J.H. (1983). Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14, 931—68.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 32, No. 6, 749-761 (2004)
DOI: 10.1080/01926230490882358
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?